Qube Research & Technologies (QRT)
AKCA

Qube Research & Technologies (QRT)’s Akcea Therapeutics Inc AKCA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-71,689
Closed -$1.3M – 2364
2020
Q3 		$1.3M Buy
71,689
+55,346
+339% +$785K 0.02% 747
2020
Q2 		$224K Buy
+16,343
New +$252K ﹤0.01% 1398
2020
Q1 		– Sell
-10,072
Closed -$171K – 1878
2019
Q4 		$171K Buy
+10,072
New +$187K 0.01% 1419

Qube Research & Technologies (QRT)'s AKCA Position: Q4 2020 in Review

Qube Research & Technologies (QRT) sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 71,689 shares — an estimated $1.3M sold.

Qube Research & Technologies (QRT) first reported a position in AKCA in Q4 2019 and held it in 3 quarters. The position peaked at $1.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Qube Research & Technologies (QRT) reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 71,689 Akcea Therapeutics Inc shares in Q4 2020, an estimated $1.3M.
  • Qube Research & Technologies (QRT) first reported a position in Akcea Therapeutics Inc in Q4 2019 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Akcea Therapeutics Inc position peaked at $1.3M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2020, filed 16 Feb 2021.